Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to -$1.0 million.

  • iSpecimen's Cash from Investing Activities fell 45570.68% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$957892.0, marking a year-over-year decrease of 17204.52%. This contributed to the annual value of $2.0 million for FY2024, which is 12738.58% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Cash from Investing Activities is -$1.0 million, which was down 45570.68% from -$73060.0 recorded in Q4 2024.
  • iSpecimen's Cash from Investing Activities' 5-year high stood at $2.4 million during Q3 2023, with a 5-year trough of -$8.8 million in Q1 2023.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$290841.0 (2021), whereas its average is -$616349.2.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 249115.56% in 2023, then skyrocketed by 53421.56% in 2024.
  • iSpecimen's Cash from Investing Activities (Quarter) stood at -$304195.0 in 2021, then crashed by 439.76% to -$1.6 million in 2022, then soared by 55.96% to -$723043.0 in 2023, then surged by 89.9% to -$73060.0 in 2024, then plummeted by 1268.74% to -$1.0 million in 2025.
  • Its Cash from Investing Activities was -$1.0 million in Q3 2025, compared to -$73060.0 in Q4 2024 and -$179951.0 in Q3 2024.